|
Nutritional determinants of breast cancer
|
41/2016
|
GOVERNMENT OF NAVARRA
|
University of Navarra
|
2016 GN HEALTH
|
05-12-2016
|
47.004,31€
|
-
|
|
Characterization and targeting of an oncogenic lncRNA in colorectal cancer.
|
36/2016
|
GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH
|
Foundation for Applied Medical research
|
2016 HEALTH research and development PROJECTS
|
05-12-2016
|
63.495,94€
|
ERDF funds
|
|
Detection, annotation and analysis of the role of eRNAs in Multiple Myeloma.
|
40_2016
|
GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH
|
Foundation for Applied Medical research
|
2016 HEALTH research and development PROJECTS
|
05-12-2016
|
63.549,00€
|
ERDF funds
|
|
POTENTIAL OF IN VIVO GENE EDITING THROUGH CRISPR/Cas FOR TREATMENT OF PRIMARY HYPEROXALURIA
|
|
GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH
|
Foundation for Applied Medical research
|
2016 HEALTH research and development PROJECTS
|
05-12-2016
|
54.964,25€
|
ERDF funds
|
|
Understanding the role of lung stem cells in pulmonary fibrosis
|
|
GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH
|
Foundation for Applied Medical research
|
2016 HEALTH research and development PROJECTS
|
05-12-2016
|
64.316,05€
|
ERDF funds
|
|
Risk of unintentional injury in ADHD and the possible protective effect of medication: a systematic review and meta-analysis.
|
89/2016
|
GOVERNMENT OF NAVARRA
|
University of Navarra
|
2016 GN HEALTH
|
05-12-2016
|
10.264,00€
|
-
|
|
Bacterial dysentery vaccination using intranasal patches
|
PI16/00071
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
86.515,00€
|
ERDF funds
|
|
Study of the immune response induced by autologous dendritic cell vaccines in breast cancer patients for the development of new therapeutic strategies.
|
PI16/01245
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
96.800,00€
|
ERDF funds
|
|
TMPRSS4: a novel biomarker and therapeutic target in poor prognosis squamous cell lung carcinoma
|
PI16/01352
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
98.615,00€
|
ERDF funds
|
|
Potential of in vivo gene editing using CRISPR/Cas for the treatment and modeling of primary hyperoxaluria.
|
PI16/00150
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
2016 - HEALTH research and development PROJECTS
|
30-11-2016
|
80.465,00€
|
ERDF funds
|
|
New experimental approaches to the diagnosis and treatment of cholangiocarcinoma.
|
PI16/01126
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
2016 - HEALTH research and development PROJECTS
|
30-11-2016
|
96.195,00€
|
ERDF funds
|
|
Molecular analysis of non-small cell lung carcinoma using state-of-the-art platforms for the development of prognostic profiles and new therapeutic tools.
|
PI16/01821
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
2016 - HEALTH research and development PROJECTS
|
30-11-2016
|
128.865,00€
|
ERDF funds
|
|
Exploiting SR-B1 for novel immunomodulatory drug development
|
PI16/00668
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
2016 - HEALTH research and development PROJECTS
|
30-11-2016
|
110.715,00€
|
ERDF funds
|
|
Treatment of myocardial infarction and prevention of adverse remodeling by application of anti-fibrotic growth factors and microRNAs.
|
PI16/00129
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
2016 - HEALTH research and development PROJECTS
|
30-11-2016
|
98.615,00€
|
ERDF funds
|
|
EPICA: Dual epigenetic targeting and immunotherapy to fight against cancer.
|
AC16/00041
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
TRANSCAN-2
|
30-11-2016
|
144.159,40€
|
ERDF funds
|
|
HEPAMUT: Mutated neo-antigens in hepatocellular carcinoma.
|
AC16/00065
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
TRANSCAN-2
|
30-11-2016
|
87.216,80€
|
ERDF funds
|
|
LYMIT-DIS: Targeted lymphatic and microvessel treatment in metabolic-disease HFpEF
|
AC16/00020
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
ERA-CVD
|
30-11-2016
|
99.825,00€
|
ERDF funds
|
|
LIPCAR-HF: Lipcar, a prognostic marker of heart failure with reduced ejection fraction.
|
AC16/00016
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
ERA-CVD
|
30-11-2016
|
99.746,35€
|
ERDF funds
|
|
Role of the NKX2-3 homeobox protein in the biology and therapy of marginal zone B lymphomas.
|
PI16/00581
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
2016 - HEALTH research and development PROJECTS
|
30-11-2016
|
236.252,50€
|
ERDF funds
|
|
Detection and functional validation of plasma cell-specific long non-coding RNAs in Multiple Myeloma.
|
PI16/02024
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
2016 - HEALTH research and development PROJECTS
|
30-11-2016
|
98.615,00€
|
ERDF funds
|
|
Okapi Cohort (Observational Kinshasa AIDS Prevention Initiative): Sexual behaviors after committee and voluntary HIV diagnosis, HIV subtypes and antiretroviral resistance.
|
PI16/01908
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
53.240,00€
|
ERDF funds
|
|
Tolerance induction with vitamin d3-treated myelin-loaded dendritic cells in patients with multiple sclerosis.
|
PI16/01797
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
55.055,00€
|
ERDF funds
|
|
Study of the interaction of adipokines and myokines in the development of obesity and associated comorbidities.
|
PI16/00221
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
92.565,00€
|
ERDF funds
|
|
Lung cancer screening in COPD patients with leave radiation dose CT: analysis of the study cohort.
National Lung cancer Screening Trial (NLST)-ACRIN study cohort
|
PI16/01149
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
19.965,00€
|
ERDF funds
|
|
technological development and clinical validation of an adaptive radiation therapy strategy in lung cancer
|
PI16/00899
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
74.415,00€
|
ERDF funds
|
|
Study of the antifibrogenic action of omega-3 fatty acids : Therapeutic applications.
|
PI16/02081
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
139.755,00€
|
ERDF funds
|
|
Reduction of the radiation dose received by the patient in the PET/CT programs of study .
|
PI16/00270
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
50.215,00€
|
ERDF funds
|
|
Changes in adipose tissue plasticity after bariatric surgery and its role in the improvement of associated comorbidities.
|
PI16/01217
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
260.452,50€
|
ERDF funds
|
|
Both phenotypic and genotypic characterization of histaminergic angioedema.
|
PI16/01304
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
90.750,00€
|
ERDF funds
|
|
Modulating the immune system with oncolytic adenoviruses as a strategy for diffuse stem tumors (DIPGs).
|
PI16/00066
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
86.515,00€
|
ERDF funds
|
|
|
|
|
|
|
|
|
